Click here to learn more about

THE ONLY IG WITH TWO NEUROMUSCULAR INDICATIONS

US-GGL-0670v1.0 07/24

GAMMAGARD LIQUID [Immune Globulin Infusion (Human)] 10% is indicated as a replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients two years of age or older, as maintenance therapy to improve muscle strength and disability in adult patients with Multifocal Motor Neuropathy (MMN). Click here to learn more about an additional neuromuscular indication.

GAMMAGARD LIQUID for Primary Immunodeficiency (PI) Resources

Support for your patients with PI

We know you want to be there for your patients with PI to support them throughout their treatment journey. That’s why we’ve put together resources to help equip your patients and their loved ones with the information they need to lead a healthy life while living with PI.

Resources for patients with PI

Welcome to Takeda Patient Support

When your patient enrolls, we’re here to help them gain access to their prescribed Takeda medication. Our dedicated specialists provide several services, including:

  • Benefits investigation to help determine your patient’s insurance benefits
  • Prior authorization (PA), reauthorization, and appeals information in coordination with your patient’s insurance company to determine any requirements
  • Financial assistance options including the Takeda Patient Support Co-Pay Assistance Program. The program may cover up to 100% of your patient’s out-of-pocket co-pay costs, if they’re eligible*†
  • Education and training about their prescribed Takeda treatment or condition from nursing professionals. Our nurses cannot provide medical advice
  • Specialty pharmacy triage, coordination, and more

Need Assistance?

Our support specialists are never more than a tap or call away — 1-866-861-1750,
Monday through Friday, 8 am to 8 pm ET.

Need to enroll your patient?

Visit our convenient online enrollment portal at TakedaPatientSupport.com/hcp.

You can also enroll your patient by faxing the completed Start Form to 1-855-268-1826.

If English is not your patient’s preferred language, we can assist them in a language of their choosing.

*Must meet eligibility requirements.
*IMPORTANT NOTICE: Takeda’s Co-pay Assistance Program ("the Program") provides financial support for commercially insured patients who qualify for the Program. Participation in the Program and provision of financial support is subject to all Program terms and conditions, including but not limited to eligibility requirements, the Program maximum benefit per claim and the annual calendar year Program maximum (“Annual Program Maximum”). The Annual Program Maximum for your prescribed Takeda product can be found by visiting: https://www.takedapatientsupport.com/s/copay. By enrolling in the Program, you agree that the Program is intended solely for the benefit of you—not health plans and/or their partners. Further, you agree to comply with all applicable requirements of your health plan. The Program cannot be used if the patient is a beneficiary of, or any part of the prescription is covered by: 1) any federal, state, or government-funded healthcare program (Medicare, Medicare Advantage, Medicaid, TRICARE, etc.), including a state pharmaceutical assistance program (the Federal Employees Health Benefit (FEHB) Program is not a government-funded healthcare program for the purpose of this offer), 2) the Medicare Prescription Drug Program (Part D), or if the patient is currently in the coverage gap, or 3) insurance that is paying the entire cost of the prescription. No claim for reimbursement of the out-of-pocket expense amount covered by the Program shall be submitted to any third-party payer, whether public or private. Some health plans have established programs referred to as ‘co-pay maximizer’ programs. A co-pay maximizer program is one in which the amount of a patient’s out-of-pocket costs is adjusted to reflect the availability of support offered by a manufacturer’s co-pay assistance program. If you are enrolled in a co-pay maximizer program, your Annual Program Maximum may vary over time to ensure the program funds are used for your benefit (for the benefit of the patient). Takeda also reserves the right to reduce or eliminate the co-pay assistance available to patients enrolled in an insurance plan that utilizes a co-pay maximizer program. If you learn your health plan has implemented a co-pay maximizer program, you agree to notify the Program immediately by calling 1-866-861-1750. It may be possible that you are unaware whether you are subject to a co-pay maximizer program when you enroll or re-enroll in the Program. Takeda will monitor program utilization data and reserves the right to discontinue assistance under the Program at any time if Takeda determines that you are subject to a co-pay maximizer, or similar program. The Program only applies in the United States, including Puerto Rico and other U.S. territories, and does not apply where prohibited by law, taxed, or restricted. This does not constitute health insurance. Void where use is prohibited by your insurance provider. If your insurance situation changes you must notify the Program immediately at 1-866-861-1750. Coverage of certain administration charges will not apply for patients residing in states where it is prohibited by law. This Program offer is not transferable and is limited to one offer per person and may not be combined with any other coupon, discount, prescription savings card, rebate, free trial, patient assistance, co-pay maximizer, alternative funding program, co-pay accumulator, or other offer, including those from third parties and companies that help insurers or health plan manage costs. Not valid if reproduced. By utilizing the Program, you hereby accept and agree to abide by these terms and conditions. Any individual or entity who enrolls or assists in the enrollment of a patient in the Program represents that the patient meets the eligibility criteria and other requirements described herein. You must meet the Program eligibility requirements every time you use the Program. Takeda reserves the right to rescind, revoke, or amend the Program at any time without notice, and other terms and conditions may apply.

If your patients’ medication is dispensed by specialty pharmacy. US-NON-9235v1.0 02/23

Visit TakedaPatientSupport.com/HCP/s/

MyIgSource

This is an online resource that offers information and support for patients at diagnosis and throughout their PI journey. It is open to all PI patients and their caregivers regardless of which treatment they are on.

Your patients can visit MyIgSource.com or call 1-855-250-5111 to:

  • Learn more about living with and managing their condition
  • Sign up to receive educational materials about PI
  • Connect via phone or online with patient advocates who have PI or who have loved ones with PI
  • Register for events focusing on PI disease education topics

Third-party links for PI patients

Immune Deficiency Foundation (IDF)

The IDF site provides timely information and valuable resources for patients and families living with PI by:

  • Helping patients gain a broader understanding of PI through education and outreach efforts
  • Promoting, participating in, and conducting research about PI and its treatment options
  • Addressing patient needs through programs that focus on issues such as insurance reimbursement, ensuring the safety and availability of immunoglobulin therapy, and maintaining and enhancing patient access to treatment options
Visit primaryimmune.org

Jeffrey Modell Foundation (JMF)

The JMF is a public charity that offers a Primary Immunodeficiency Resource Center online at http://www.info4pi.org.

Visit info4pi.org
Man looking at a computer while drinking his coffee.